(Q73827350)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12928126%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Phase I/II study of concurrent twice-weekly paclitaxel and weekly cisplatin with radiation therapy for stage III non-small cell lung cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12928126%20AND%20SRC:MED&resulttype=core&format=json

non-small-cell lung carcinoma

7 November 2019

main subject

1 reference

1 reference

1 reference

B Solomon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12928126%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

D L Ball

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12928126%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

G Richardson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12928126%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J G Smith

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12928126%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Millward

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12928126%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M MacManus

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12928126%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M Michael

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12928126%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

A Wirth

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12928126%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

C O'Kane

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12928126%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

L Muceniekas

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12928126%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

G Ryan

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12928126%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

D Rischin

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12928126%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 September 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12928126%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12928126%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12928126%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12928126%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

353-361

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12928126%20AND%20SRC:MED&resulttype=core&format=json

Five-year survival after hyperfractionated radiation therapy for non-small-cell carcinoma of the lung (NSCCL): results of RTOG protocol 81-08.

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900235-6

7 January 2021

Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung. Report by the radiation therapy oncology group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900235-6

7 January 2021

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900235-6

7 January 2021

Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900235-6

7 January 2021

Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900235-6

7 January 2021

Paclitaxel-based combination chemotherapy in advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900235-6

7 January 2021

Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900235-6

7 January 2021

Radiosensitization with chemotherapeutic agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900235-6

7 January 2021

Paclitaxel as a radiosensitiser: a proposed schedule of administration based on in vitro data and pharmacokinetic calculations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900235-6

7 January 2021

Phase I study of paclitaxel as a radiation sensitizer in the treatment of mesothelioma and non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900235-6

7 January 2021

Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage III non-small-cell lung cancer: a California Cancer Consortium phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900235-6

7 January 2021

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900235-6

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900235-6

7 January 2021

Combined modality therapy for unresectable stage III non-small cell lung cancer: new chemotherapy combinations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900235-6

7 January 2021

Phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900235-6

7 January 2021

Weekly paclitaxel and cisplatin with concurrent radiotherapy in locally advanced non-small-cell lung cancer: a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900235-6

7 January 2021

Factors affecting the risk of brain metastases after definitive chemoradiation for locally advanced non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900235-6

7 January 2021

A phase II study of paclitaxel, carboplatin, and hyperfractionated radiation therapy for locally advanced inoperable non-small-cell lung cancer (a Vanderbilt Cancer Center Affiliate Network Study)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900235-6

7 January 2021

Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900235-6

7 January 2021

Paclitaxel (Taxol) and carboplatin followed by concomitant paclitaxel, cisplatin and radiotherapy for inoperable stage III NSCLC.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900235-6

7 January 2021

Early mortality after radical radiotherapy for non-small-cell lung cancer: comparison of PET-staged and conventionally staged cohorts treated at a large tertiary referral center

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2803%2900235-6

7 January 2021

10.1016/S0169-5002(03)00235-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12928126%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference